DRREDDY's weekly performance was lackluster, with a return of -0.7%, indicating a decline in value. The stock's volatility was moderate at 11.6%, which is relatively in line with its peers. Compared to its peers, DRREDDY outperformed DIVISLAB and HINDUNILVR but underperformed SUNPHARMA. The stock's Sharpe ratio of -0.24 and max drawdown of -1.32% suggest that it was a relatively risky investment this week.

[Volatility: 11.6%]